Shree Ganesh Biotech filed a SEBI Regulation 32(1) compliance disclosure stating no unutilized funds from past public issues.
The company confirmed zero unutilized proceeds as of March 31, 2026, and the current date (May 14, 2026).
No Annexure-A information was provided as the disclosure confirms full utilization of all historical issue proceeds.